Takashi Taga

19PUBLICATIONS
115CO-AUTHORS
AutoimmunityMedical infection agents (incl. prions)Regenerative medicine (incl. stem cells)Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 22, 2026
Polyclonal evolution of lymphoproliferative disorders in XLP1.

|Apr 29, 2026
Multi-omics analysis of pediatric minimally differentiated acute myeloid leukemia reveals RUNX1-driven stemness and chemoresistance.

|Aug 05, 2024
Azacitidine treatment for myeloid leukemia associated with Down syndrome: A nationwide retrospective study in Japan.

Shota Kato, Kentaro Nakashima, Genki Yamato

|Jul 02, 2024
High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.

Masahiro Yoshitomi, Shin-Ichi Tsujimoto, Junji Ikeda

|Apr 17, 2024
KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia.

Shinju Iyoda, Kenichi Yoshida, Kota Shoji

|Mar 21, 2024
Landscape of driver mutations and their clinical effects on Down syndrome-related myeloid neoplasms.

Tomohiko Sato, Kenichi Yoshida, Tsutomu Toki

Pageof 4

Frequent Collaborators

14 joint publications

Daisuke Tomizawa

7 joint publications

Kiminori Terui

7 joint publications

Daisuke Hasegawa

7 joint publications

Hiroshi Moritake